Platform
T-CAMP
Next-Generation T-Cell Therapy Manufacturing Platform
MC – EXP
T Cell Activation via Cell-Cell Interaction
Antibody immobilized on bio-membrane
T- CAST
Proprietary optimized vessel & non- invasive real-time imaging
Optimization of immune cell culture conditions
Predictive modeling of culture conditions
Individualized culture optimization
T-GUNS
Redefining TCR-T Therapies with Monomeric TCRs
mRNA based safe expression
enhanced stability
neoantigen specificity
overcome TME with ISTx
Cell Theraphy Process
01
Blood Collection
Only about 40ml of the patient’s blood is collected, and immune cells (PBMCs) are isolated for preparation.
02
Rapid Expansion with
Enhanced Functionality
By mimicking in vivo environment, T cells are rapidly expanded within 7 days, with enhanced stemness and bio-persistency.
03
Safe Patient-Tailored
TCR Expression
Safe TCR expression via mRNA delivery using patient-derived monomeric TCR libraries.
04
Patient-Friendly Therapy
Achieves therapeutic effect with only one-third of the conventional dose.
Based on the patient’s own (autologous) cells, making the therapy safe, simple, and cost-effective.